AU Patent

AU2010297290A1 — Heterocyclic antiviral compounds

Assigned to F Hoffmann La Roche AG · Expires 2012-03-15 · 14y expired

What this patent protects

Compounds having the formula I wherein R, R, R, R, and Rare as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

USPTO Abstract

Compounds having the formula I wherein R, R, R, R, and Rare as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

Drugs covered by this patent

Patent Metadata

Patent number: AU2010297290A1
Jurisdiction: AU
Classification: —
Expires: 2012-03-15
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.